|
Name |
dehydropestalotin
|
| Molecular Formula | C11H16O4 | |
| IUPAC Name* |
6-(1-hydroxypentyl)-4-methoxypyran-2-one
|
|
| SMILES |
CCCCC(O)c1cc(OC)cc(=O)o1
|
|
| InChI |
InChI=1S/C11H16O4/c1-3-4-5-9(12)10-6-8(14-2)7-11(13)15-10/h6-7,9,12H,3-5H2,1-2H3
|
|
| InChIKey |
FWFKXWDSIIPMJT-UHFFFAOYSA-N
|
|
| Synonyms |
NA
|
|
| CAS | NA | |
| PubChem CID | NA | |
| ChEMBL ID | NA |
Chemical Classification: |
|
|
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
| Molecular Weight: | 212.24 | ALogp: | 1.9 |
| HBD: | 1 | HBA: | 4 |
| Rotatable Bonds: | 5 | Lipinski's rule of five: | Accepted |
| Polar Surface Area: | 59.7 | Aromatic Rings: | 1 |
| Heavy Atoms: | 15 | QED Weighted: | 0.814 |
| Caco-2 Permeability: | -4.791 | MDCK Permeability: | 0.00003680 |
| Pgp-inhibitor: | 0.047 | Pgp-substrate: | 0.73 |
| Human Intestinal Absorption (HIA): | 0.029 | 20% Bioavailability (F20%): | 0.368 |
| 30% Bioavailability (F30%): | 0.99 |
| Blood-Brain-Barrier Penetration (BBB): | 0.541 | Plasma Protein Binding (PPB): | 82.26% |
| Volume Distribution (VD): | 0.741 | Fu: | 24.19% |
| CYP1A2-inhibitor: | 0.583 | CYP1A2-substrate: | 0.952 |
| CYP2C19-inhibitor: | 0.252 | CYP2C19-substrate: | 0.702 |
| CYP2C9-inhibitor: | 0.1 | CYP2C9-substrate: | 0.881 |
| CYP2D6-inhibitor: | 0.019 | CYP2D6-substrate: | 0.876 |
| CYP3A4-inhibitor: | 0.022 | CYP3A4-substrate: | 0.288 |
| Clearance (CL): | 10.329 | Half-life (T1/2): | 0.735 |
| hERG Blockers: | 0.049 | Human Hepatotoxicity (H-HT): | 0.272 |
| Drug-inuced Liver Injury (DILI): | 0.193 | AMES Toxicity: | 0.03 |
| Rat Oral Acute Toxicity: | 0.099 | Maximum Recommended Daily Dose: | 0.292 |
| Skin Sensitization: | 0.365 | Carcinogencity: | 0.074 |
| Eye Corrosion: | 0.248 | Eye Irritation: | 0.857 |
| Respiratory Toxicity: | 0.119 |
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC006023 | ![]() |
0.783 | D02XJY | ![]() |
0.286 | ||
| ENC003693 | ![]() |
0.735 | D0T1LK | ![]() |
0.284 | ||
| ENC006022 | ![]() |
0.717 | D09GYT | ![]() |
0.246 | ||
| ENC005859 | ![]() |
0.647 | D04UTT | ![]() |
0.240 | ||
| ENC005860 | ![]() |
0.647 | D0DJ1B | ![]() |
0.239 | ||
| ENC002737 | ![]() |
0.560 | D00XWD | ![]() |
0.238 | ||
| ENC005908 | ![]() |
0.528 | D05CKR | ![]() |
0.236 | ||
| ENC005618 | ![]() |
0.484 | D02HXS | ![]() |
0.229 | ||
| ENC002549 | ![]() |
0.476 | D0D1DI | ![]() |
0.220 | ||
| ENC002733 | ![]() |
0.459 | D0Q1IT | ![]() |
0.220 | ||